CNTA – centessa pharmaceuticals plc - american depositary shares (US:NASDAQ)
Stock Stats
News
Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications [Yahoo! Finance]
Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications 
Centessa Pharmaceuticals (NASDAQ:CNTA) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $62.00 price target on the stock.
Analysts Boost Centessa Pharmaceuticals plc (CNTA) Price Targets as Sleep Disorder Drug Shows Breakthrough Results [Yahoo! Finance]
Centessa Pharmaceuticals (NASDAQ:CNTA) had its price target raised by analysts at B. Riley from $33.00 to $42.00. They now have a "buy" rating on the stock.
Form 8-K Centessa Pharmaceuticals For: Dec 05
Form 4 Centessa Pharmaceuticals For: Dec 09 Filed by: Accardi Mario Alberto
Form 144 Centessa Pharmaceuticals Filed by: Accardi Mario Alberto
Form 4 Centessa Pharmaceuticals For: Dec 08 Filed by: Accardi Mario Alberto
Form 144 Centessa Pharmaceuticals Filed by: Accardi Mario Alberto
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.